Joanne E. Tomassini
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, SARS-CoV-2 and COVID-19 Research, Pharmaceutical Economics and Policy
Most-Cited Works
- → Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy(2018)2,281 cited
- → Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase(2021)653 cited
- → A Bivalent Omicron-Containing Booster Vaccine against Covid-19(2022)641 cited
- → PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer(2017)593 cited
- → P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro(1997)540 cited
- → Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs(2003)337 cited
- → Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro(2003)324 cited
- → cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1.(1989)249 cited
- → A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties(2004)233 cited
- → Structure−Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase(2004)187 cited